QualityStocks SUBMIT AN ARTICLE

NexMed Inc. (NEXM:NASDAQ) is an innovative drug developer that is leveraging its proprietary NexACT transdermal drug delivery technology to produce a host of new medical treatments. The company’s drugs address a variety of health conditions such as nail fungus, sexual disorders and more.

NexMed offers large pharmaceutical companies the opportunity to incorporate NexACT into their existing drugs. This allows these large drug companies to save considerably on R&D costs while developing new patient-friendly transdermal products and extending patent lifespans and brand equity.

NexMed’s drugs incorporate NexACT drug delivery technology which offers several competitive advantages in the treatment of various illnesses. The NexACT penetration enhancers are designed to be structurally similar to and biologically compatible with the skin structure, are non-toxic, biodegradable, and enable drug candidates to efficiently overcome the skin or mucosal membranes. The company’s technology has applications in transdermal dosage forms such as creams, ointments, lotions, gels, and sprays.

Let us hear your thoughts below: